The University of Chicago Header Logo


Peter Riedell to Antibodies, Monoclonal, Humanized

This is a "connection" page, showing publications Peter Riedell has written about Antibodies, Monoclonal, Humanized.
  1. Safety and efficacy of tisagenlecleucel plus pembrolizumab in patients with r/r DLBCL: phase 1b PORTIA study results. Blood Adv. 2023 06 13; 7(11):2283-2286.
    View in: PubMed
    Score: 0.159
  2. Chimeric Antigen Receptor T Cell Therapy During the COVID-19 Pandemic. Biol Blood Marrow Transplant. 2020 07; 26(7):1239-1246.
    View in: PubMed
    Score: 0.032
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.